CLINICAL_TRIALS
trial_result
· 2015-11-20
Clinical Trial Update: Open-label Study of STA-9090 for Patients With Metastatic Breast Cancer [Phase 2]
Summary
Phase 2 open-label study of ganetespib (STA-9090) in metastatic breast cancer completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-11-20